Genital Warts Treatment

Safe, Effective Treatment

Genital Warts Treatment Options

MedExpress offers three treatments: Warticon Cream, Warticon Solution, and Aldara

Warticon Cream

  • Contains the active ingredient podophyllotoxin – this stops the infected viral cells from dividing, which stops them from increasing in number. As the wart cells die, new healthy tissue grows in their place.
  • Topical treatment for genital warts.
  • Applied twice daily for three consecutive days followed by four days of no treatment.
  • This should be repeated weekly if necessary for a maximum of four 3-day courses.
  • The cream is white and disappears after application.
  • Prescription Only Medication (POM).
  • Common to very common side effects include: skin erosion, application site irritation or burning, application site itch.
  • Clearance rate range: 43-70%.
  • Recurrence rate range: 6-55%.

Warticon Solution

  • Contains the active ingredient podophyllotoxin – this stops the infected viral cells from dividing, which stops them from increasing in number. As the wart cells die, new healthy tissue grows in their place.
  • Applied twice daily for three consecutive days followed by four days of no treatment.
  • This should be repeated weekly if necessary for a maximum of four 3-day courses.
  • The solution is be blue and can leave a temporary stain after application.
  • The solution may be easier for men to apply due to the position of their genitals.
  • Prescription Only Medication (POM).
  • Common to very common side effects include: skin erosion, application site irritation or burning, application site itch.
  • Clearance rate range: 45-83%.
  • Recurrence rate range: 13-100%.

Aldara Cream

  • Contains the active ingredient Imiquimod – this is an immune response modifier.
  • Topical treatment for genital warts.
  • Apply once daily three times a week.
  • Can be used for up to 16 weeks at a time.
  • Contains the active ingredient imiquimod.
  • Prescription Only Medication (POM).
  • Common to very common side effects include: application site pain, application site burning or irritation,application site itch.
  • Clearance rate range: 35- 68%.
  • Recurrence rate range: 6-26%.
  • In one study, 119 imiquimod-treated female patients, the combined total clearance rate was 60% as compared to 20% in 105 vehicle-treated patients.
  • In another study, 157 imiquimod-treated male patients, the combined total clearance rate was 23% as compared to 5% in 161 vehicle-treated patients.